Copyright
©The Author(s) 2015.
World J Gastroenterol. Sep 21, 2015; 21(35): 10091-10103
Published online Sep 21, 2015. doi: 10.3748/wjg.v21.i35.10091
Published online Sep 21, 2015. doi: 10.3748/wjg.v21.i35.10091
Ingredients | Control diet (AIN-76) | BSEx diet |
Casein | 25.00% | 25.00% |
Cornstarch | 40.10% | 33.86% |
Sucrose | 20.00% | 20.00% |
Corn oil | 5.00% | 5.00% |
Mineral mixture | 3.50% | 3.50% |
Vitamin mixture | 1.00% | 1.00% |
Choline bitartrate | 0.40% | 0.40% |
Cellulose | 5.00% | 5.00% |
BSEx | ||
Glucoraphanin | - | 0.34% |
Others | - | 5.90% |
Gene symbol | Sequence (5'→3') | |
Rpl10a | Forward | GAAGAAGGTGCTGTGTTTGGC |
Reverse | TCGGTCATCTTCACGTGGC | |
Arbp | Forward | GGCGACCTGGAAGTCCAACTA |
Reverse | CATTGTCTGCTCCCACAATGAA | |
Rpl15 | Forward | GCTTTAGTAGCAGCTGGTGTGTGA |
Reverse | ACCCAAGACGAATTGATTGGAA | |
Rps16 | Forward | TCCAAGGGTCCGCTGCAGTC |
Reverse | CGTTCACCTTGATGAGCCCATT | |
Rpl3 | Forward | TGTATTGGAGCTTGGCATCCTG |
Reverse | ACCATCCTTGATGAGGTAGCCTTG | |
Rps18 | Forward | AAGTTTCAGCACATCCAGCGAGTA |
Reverse | TTGGTGAGGTCAATGTCTGCTTTC | |
Rps3 | Forward | GATCATGTGAGCATTGTGGAACCTA |
Reverse | CTCCAGATGCAGCTGCCAAG | |
Cyp1a2 | Forward | TCAACCTCGTGAAGAGCAGCA |
Reverse | GTCCTGGATACTGTTCTTGTTGAAGTC | |
Gstm1 | Forward | TTCGTGCAGACATTGTGGAGA |
Reverse | CTTGCCCAGGAACTCAGAGTAGA | |
Gclc | Forward | GTGGACACCCGATGCAGTATTC |
Reverse | CATCCACCTGGCAACAGTCATTAG | |
Gsta3 | Forward | AATAGGCTGAGCAGGGCTGATG |
Reverse | GGTTGCTGACTCTGGTTCTCAGG | |
Gstt3 | Forward | ATGCCTTTGCCCAGGTGAAC |
Reverse | GTGTGCTGCCAAGCCAGGTA | |
Gstp1 | Forward | GAGGACCTTCGATGCAAATATGGTA |
Reverse | CTGGGACAGCAGGGTCTCAA |
KEGG ID | Pathway | FDR-corrected P value | |
Up-regulated | rno03010 | Ribosome | 3.97 × 10-43 |
rno00980 | Metabolism of xenobiotics by cytochrome P450 | 0.001186149 | |
rno00982 | Drug metabolism | 0.004009591 | |
Down-regulated | rno00071 | Fatty acid metabolism | 2.42 × 10-17 |
rno03320 | PPAR signaling pathway | 2.42 × 10-12 | |
rno00280 | Valine, leucine and isoleucine degradation | 5.75 × 10-8 | |
rno00620 | Pyruvate metabolism | 8.79 × 10-7 | |
rno01040 | Biosynthesis of unsaturated fatty acids | 8.34 × 10-7 | |
rno00650 | Butanoate metabolism | 1.21 × 10-6 | |
rno00830 | Retinol metabolism | 5.97 × 10-6 | |
rno00982 | Drug metabolism | 7.15 × 10-6 | |
rno00640 | Propanoate metabolism | 1.06 × 10-5 | |
rno00020 | Citrate cycle (TCA cycle) | 4.94 × 10-5 | |
rno00120 | Primary bile acid biosynthesis | 5.63 × 10-5 | |
rno00140 | Steroid hormone biosynthesis | 7.09 × 10-4 | |
rno00561 | Glycerolipid metabolism | 7.78 × 10-4 | |
rno00010 | Glycolysis/gluconeogenesis | 0.003660561 | |
rno00380 | Tryptophan metabolism | 0.003952492 | |
rno00983 | Drug metabolism | 0.004286518 | |
rno00500 | Starch and sucrose metabolism | 0.009275005 | |
rno00980 | Metabolism of xenobiotics by cytochrome P450 | 0.024561245 |
Ingenuity canonical pathways | -log(B-H P value) | Ratio | Molecules |
EIF2 signaling | 22.5 | 0.1830 | RPL18, RPL14, RPLP0, RPL7, Rpl7a, RPL41, RPS4X, RPS12, RPL22L1, RPL31, RPS26, RPS13, RPL15, RPS16, RPS7, RPS19, RPS6, RPS15A, RPL11, RPS2, RPS5, RPL26, RPS18, RPL34, RPSA, RPL13, Gm11425, RPS9, RPS3, RPS23, RPL23A, RPL27A, RPS8, RPL18A, RPS11, RPL3, RPLP2 |
Regulation of eIF4 and p70S6K Signaling | 7.57 | 0.1150 | RPS18, RPS12, RPS4X, RPS26, RPS13, RPSA, RPS3, RPS16, RPS9, RPS7, RPS23, PPP2CA, RPS19, RPS6, RPS8, ITGB1, RPS15A, RPS11, RPS2, RPS5 |
mTOR Signaling | 6.49 | 0.1000 | RND3, RPS18, RPS12, RPS4X, HMOX1, RPS26, RPS13, RPSA, RPS3, RPS16, RPS9, RPS7, RPS23, PPP2CA, RPS19, RPS6, RPS8, RPS15A, RPS11, RPS2, RPS5 |
Nrf2-mediated oxidative stress response | 3.85 | 0.0890 | GPX2, GSTM5, ACTG1, AKR1A1, GCLC, HSPB8, GSTP1, GSTA1, HMOX1, GSTM1, FTL, JUN, EPHX1, NFE2L2, AKR7A3, ACTB, NQO1 |
Metabolism of xenobiotics by cytochrome P450 | 3.84 | 0.0612 | GSTM5, GSTM1, Gstt3, CYP2B6, AKR1A1, UGT2B15, Cyp2c40, CYP1A2, GSTP1, GSTA1, AKR1C3, UGT2B4 |
Glutathione metabolism | 2.88 | 0.0899 | GPX2, GSTM5, GSTM1, Gstt3, GCLC, PRDX6, GSTP1, GSTA1 |
Arachidonic acid metabolism | 2.09 | 0.0485 | GPX2, LTC4S, CYP2B6, CYP4A22, PRDX6, PLA2G2A, Cyp2c40, PLA2G16, CYP1A2, AKR1C3 |
Acute phase response signaling | 2.00 | 0.0734 | APOA1, A2M, C4BPA, SERPINA3, RBP7, C4B, HMOX1, ORM1/ORM2, C4BPB, FTL, JUN, HP, HPX |
B cell development | 1.78 | 0.1210 | HLA-DMA, HLA-DRB1, HLA-DRA, HLA-DMB |
Aryl hydrocarbon receptor signaling | 1.72 | 0.0692 | HSPB1, GSTM5, GSTM1, MYC, RARB, JUN, NFE2L2, CYP1A2, GSTP1, NQO1, GSTA1 |
ERK/MAPK Signaling | 1.56 | 0.0588 | HSPB1, DUSP1, MYC, YWHAZ, PPP2CA, PRKAR2A, YWHAG, DUSP6, PLA2G2A, ITGB1, PPP1R3C, ETS1 |
Xenobiotic metabolism signaling | 1.56 | 0.0508 | GSTM5, CYP2B6, GCLC, UGT2B15, CYP1A2, GSTP1, GSTA1, HMOX1, GSTM1, FTL, PPP2CA, NFE2L2, FMO5, NQO1, UGT2B4 |
Eicosanoid signaling | 1.56 | 0.0759 | LTC4S, PTGER3, PRDX6, PLA2G2A, PLA2G16, AKR1C3 |
Complement system | 1.56 | 0.1430 | C4BPB, C6, C4BPA, C4B, C1QB |
Pentose and glucuronate interconversions | 1.56 | 0.0352 | AKR1A1, UGT2B15, AKR7A3, AKR1C3, UGT2B4 |
Gene symbol | FDR-corrected P value | Control | BSEx | ||
Mean | SD | Mean | SD | ||
Ribosome | |||||
Rpl10a | 0.0018 | 1.00 | 0.06 | 0.82b | 0.05 |
Arbp | 0.0056 | 1.00 | 0.13 | 0.86 | 0.24 |
Rpl15 | 0.0058 | 1.00 | 0.14 | 0.80 | 0.23 |
Rps16 | 0.0058 | 1.00 | 0.11 | 0.75a | 0.18 |
Rpl3 | 0.0068 | 1.00 | 0.12 | 1.07 | 0.20 |
Rps18 | 0.0086 | 1.00 | 0.06 | 1.00 | 0.17 |
Rps3 | 0.0096 | 1.00 | 0.05 | 1.34a | 0.27 |
Xenobiotic/glutathione metabolism | |||||
Cyp1a2 | < 0.0001 | 1.00 | 0.32 | 2.43b | 0.66 |
Gstm1 | < 0.0001 | 1.00 | 0.13 | 1.23 | 0.30 |
Gclc | 0.0014 | 1.00 | 0.06 | 1.32a | 0.23 |
Gsta3 | 0.0018 | 1.00 | 0.13 | 1.58a | 0.43 |
Gstt3 | 0.0018 | 1.00 | 0.19 | 1.03 | 0.05 |
Gstp1 | 0.0287 | 1.00 | 0.14 | 0.94 | 0.30 |
Marker | Control | BSEx | APAP | APAP + BSEx | ||||
Mean | SD | Mean | SD | Mean | SD | Mean | SD | |
Body weight (g) | 188.45 | 10.38 | 190.90 | 11.36 | 172.39 | 9.91 | 183.63 | 8.87 |
Body weight gain after i.p (g) | 3.88 | 1.77 | 3.59 | 1.53 | -11.21a | 3.30 | -1.05b | 2.84 |
Liver weight (g) | 8.46 | 0.44 | 9.13 | 0.69 | 6.90a | 0.58 | 8.11d | 0.85 |
Liver/body | 0.045 | 0.001 | 0.048 | 0.002 | 0.04a | 0.002 | 0.044d | 0.003 |
AST (IU/L) | 71.41 | 6.99 | 59.98 | 8.46 | 5614.41a | 1997.83 | 70.91 | 15.74 |
ALT (IU/L) | 12.51 | 0.57 | 9.81 | 1.84 | 1297.71a | 447.33 | 11.78 | 2.08 |
GST activity (U/g tissue) | 61.78 | 4.95 | 77.89 | 4.62 | 51.90c | 16.85 | 93.19b | 16.55 |
TBARS (μmol/g tissue) | 462.68 | 36.57 | 420.95 | 23.66 | 751.12a | 220.87 | 496.63 | 37.21 |
GSH (nmol/g tissue) | 2.73 | 0.26 | 2.99 | 0.29 | 1.66a | 0.59 | 2.61 | 0.75 |
Marker | Control | BSEx | D-GalN | D-GalN + BSEx | ||||
Mean | SD | Mean | SD | Mean | SD | Mean | SD | |
Body weight (g) | 237.31 | 10.49 | 235.13 | 16.38 | 224.30 | 11.14 | 225.39 | 10.76 |
Body weight gain after i.p (g) | 1.85 | 1.32 | 3.50 | 0.97 | -7.74a | 2.42 | -4.10b | 3.67 |
Liver weight (g) | 10.38 | 0.32 | 11.16 | 1.25 | 7.40a | 0.60 | 8.32b | 1.33 |
Liver/body | 0.044 | 0.001 | 0.048 | 0.002 | 0.032a | 0.001 | 0.036b | 0.005 |
AST (IU/L) | 55.73 | 8.66 | 66.30 | 24.08 | 12465.63a | 3223.97 | 4820.05b | 3094.93 |
ALT (IU/L) | 11.12 | 1.01 | 12.47 | 3.48 | 3936.46a | 777.52 | 1808.95b | 1014.04 |
GST activity (U/g tissue) | 87.92 | 10.42 | 109.43 | 23.19 | 53.15a | 8.14 | 98.04 | 15.75 |
TBARS (μmol/g tissue) | 418.96 | 33.06 | 442.34 | 41.10 | 543.81c | 45.35 | 495.42d | 54.46 |
- Citation: Yoshida K, Ushida Y, Ishijima T, Suganuma H, Inakuma T, Yajima N, Abe K, Nakai Y. Broccoli sprout extract induces detoxification-related gene expression and attenuates acute liver injury. World J Gastroenterol 2015; 21(35): 10091-10103
- URL: https://www.wjgnet.com/1007-9327/full/v21/i35/10091.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i35.10091